HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
LEGN
Legend Biotech Corporation
LEGN lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
LEGN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Weak | |
| Unavailable |
LEGN's revenue is currently healthy, and its profitability is stable, but its cash flow is weak. There isn't enough data to rate its balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
LEGN PE Valuation
LEGN has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
LEGN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
LEGN has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
LEGN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.40 | +$0.82 |
| Q1 2026 | -$0.92 | +$0.06 |
| Q4 2025 | -$0.89 | -$0.02 |
| Q3 2025 | -$0.65 | +$1.09 |
| Q2 2025 | -$1.22 | +$0.18 |
| Q1 2025 | -$0.98 | +$1.46 |
| Q4 2024 | -$0.87 | +$2.09 |
| Q3 2024 | -$1.74 | +$1.27 |
LEGN has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS's revenue has grown year over year every quarter since late 2021: $890M last quarter, up 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
LEGN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $387.5M | +52% |
| Q1 2026 | $305.1M | +56% |
| Q4 2025 | $306.4M | +64% |
| Q3 2025 | $272.3M | +70% |
| Q2 2025 | $255.1M | +37% |
| Q1 2025 | $195.1M | +108% |
| Q4 2024 | $186.5M | +135% |
| Q3 2024 | $160.2M | +67% |
LEGN has the edge over HIMS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 15% | +64 points |
| Q1 2026 | -16% | +35 points |
| Q4 2025 | -6.7% | -28 points |
| Q3 2025 | -16% | +28 points |
| Q2 2025 | -49% | -26 points |
| Q1 2025 | -51% | +13 points |
| Q4 2024 | 22% | +173 points |
| Q3 2024 | -44% | +53 points |
LEGN has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over LEGN on cash generation, producing positive trailing cash flow while its opponent burns cash.
LEGN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$41.5M | -$19.2M |
| Q1 2026 | -$111.3M | -$5.6M |
| Q4 2025 | -$126.6M | -$42.1M |
| Q3 2025 | $23.8M | +$101.7M |
| Q2 2025 | -$22.3M | -$17.2M |
| Q1 2025 | -$105.8M | -1240% |
| Q4 2024 | -$84.5M | +$18M |
| Q3 2024 | -$77.9M | -$11.6M |
LEGN has burned cash in almost every quarter: −$256M over the past year, against −$290M the year before.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
LEGN Net Leverage
LEGN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
LEGN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.8 | Neutral |
| Stochastic | 63.0 | Neutral |
LEGN's weekly RSI is 44 (neutral) and its Stochastic is 63 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
LEGN PE vs Healthcare Sector
LEGN has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
LEGN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $19.7 | 5.9% below |
| 20 week MA | $20.9 | 11% below |
| 50 week MA | $22.1 | 16% below |
| 100 week MA | $28.2 | 34% below |
| 200 week MA | $42.3 | 56% below |
LEGN is in a downtrend: it's below all five of its weekly moving averages, and 56% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
LEGN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.0 | $29.5 | -20% |
| 2021 | $29.5 | $48.7 | +65% |
| 2022 | $48.7 | $49.8 | +2.3% |
| 2023 | $49.8 | $60.2 | +21% |
| 2024 | $60.2 | $32.5 | -46% |
| 2025 | $32.5 | $22.5 | -31% |
| 2026 YTD | $22.5 | $18.5 | -18% |
LEGN has the edge over HIMS on returns for 2026, with the stronger performance.